CeriBell, Inc.

ceribell.com

What Do They Do?

Builds portable, point-of-care EEG systems combining hardware and AI algorithms for hospitals and medical groups to detect and monitor seizures and other neurological conditions in acute care.

How Do They Make Money?

revenue

Segment	Share	Revenue
Product revenue	76%
Subscription revenue	24%

Who Are Their Customers?

Ceribell sells directly to hospitals and medical groups through its U.S. sales organization. Clinicians, nurses and hospital leaders help evaluate the system, support its adoption and take part in onboarding.

Do Revenues Turn Into Profits?

No. It lost $53.4M in FY2025.

Operating income, FY2025

−66% of revenue

▲ +47% (Loss) vs FY2024 (−$39.7M, −61%)

Net income, FY2025

−60% of revenue

▲ +32% (Loss) vs FY2024 (−$40.5M, −62%)

Free cash flow, FY2025

−47% of revenue

▲ +14% (Loss) vs FY2024 (−$36.4M, −56%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +33%; vs $21.2M in Q2 FY2025
Net income: ▲ +41% (Loss); vs −$13.6M in Q2 FY2025

Product revenue share of revenue vs 75.1% in Q2 FY2025

Aug 10, 2026 Raises full-year 2026 revenue guidance The revised range is $114 million to $117 million.

Revenue over time

Product revenue Subscription revenue

$100M$50M$0

FY2023 FY2024 FY2025

Who Do They Compete With?

Competes with Natus Medical, Nihon Kohden, and Zeto

Comments